Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ENDRA Life Sciences ( (NDRA) ) just unveiled an update.
ENDRA Life Sciences disclosed a renewed compliance setback with Nasdaq’s stockholders’ equity requirements after previously regaining compliance in November 2025. Following a May 27, 2025 notice that equity had fallen below the $2.5 million threshold, the company submitted a remediation plan in July 2025 and secured an extension to November 24, 2025, ultimately achieving conditional compliance on November 18, 2025.
However, in an April 20, 2026 letter, Nasdaq staff informed ENDRA that its reported stockholders’ equity of $2,260,120 as of December 31, 2025 again failed to meet the minimum standard, triggering a potential delisting. ENDRA plans to request a hearing before a Nasdaq panel, a step that temporarily stays delisting, and is evaluating options to restore compliance, though it acknowledges uncertainty about successfully maintaining its listing status.
The most recent analyst rating on (NDRA) stock is a Buy with a $27.00 price target. To see the full list of analyst forecasts on ENDRA Life Sciences stock, see the NDRA Stock Forecast page.
Spark’s Take on NDRA Stock
According to Spark, TipRanks’ AI Analyst, NDRA is a Neutral.
The score is held down primarily by weak financial performance (no meaningful revenue, ongoing losses, cash burn, and equity erosion). Technicals provide partial support with strong upside momentum, but overbought signals add risk. Valuation is constrained by negative earnings, and the strategic-alternatives/restructuring event adds uncertainty despite potential optionality.
To see Spark’s full report on NDRA stock, click here.
More about ENDRA Life Sciences
ENDRA Life Sciences operates in the medical technology sector, focusing on diagnostic imaging solutions. The company develops products intended to improve clinical imaging capabilities, with a market focus on healthcare providers seeking advanced, cost-effective imaging tools.
Average Trading Volume: 114,720
Technical Sentiment Signal: Hold
Current Market Cap: $6.38M
Find detailed analytics on NDRA stock on TipRanks’ Stock Analysis page.